Telemedicine Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Keio University, Japan
Studies from Japan, the People's Republic of China and Italy describe new findings in hepatocellular carcinoma research
September 13th, 2006
Investigators in Japan, the People's Republic of China and Italy have published new hepatocellular carcinoma data. Study 1: Hepatocellular carcinoma (HCC) could be imaged via application of superparamagnetic iron oxide (SPIO) as a MR contrast agent. "SPIO particles are as MR contrast media composed of iron oxide crystals coated with dextran or carboxydextran. These particles are sequestered by phagocytic Kupffer cells in normal reticuloendothelial system (RES), but are not retained in tumor tissue. Consequently, there are significant differences in T2/T2* relaxation between normal RES tissue and tumors, which result in increased lesion conspicuity...
Source: Telemedicine Business Week (2006-09-13)
|
